incretin effect glp-1 Components contributing to the and the Frontiers | Variation in responses

GLP-1 agonists increase insulin release when blood sugar levels are high and reduce glucagon levels

Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease

It possesses significant antioxidant and anti-inflammatory activity, scavenging reactive oxygen species and inhibiting pro-inflammatory pathways (such as NF-B) to protect tissues from oxidative stress damage

In the Wegovy clinical program, gastroesophageal reflux disease was reported in 5% of participants, dyspepsia in 9%, and eructation in 7%, alongside nausea at 44%, diarrhea at 30%, vomiting at 24%, and constipation at 24%